Trevi Therapeutics (TRVI) Long-Term Debt Repayments (2018 - 2023)
Trevi Therapeutics (TRVI) posted quarterly Long-Term Debt Repayments of $7.7 million for Q2 2023, up 337.66% year-over-year from $1.8 million in Q2 2022, and up 337.66% quarter-over-quarter from $1.8 million in Q1 2023.
Trevi Therapeutics (TRVI) Long-Term Debt Repayments (2018 - 2023) Analysis & Trends
Trevi Therapeutics' Long-Term Debt Repayments history runs 3 years deep, the most recent figure standing at $7.7 million for Q2 2023.
- In Q2 2023, Long-Term Debt Repayments rose 337.66% year-over-year to $7.7 million; the TTM figure through Sep 2023 stood at $11.2 million (up 173.3% YoY), while the FY2022 annual figure was $5.8 million, changed N/A from the prior year.
- Long-Term Debt Repayments for Q2 2023 stood at $7.7 million, up from $1.8 million in the prior quarter.
- The five-year high for Long-Term Debt Repayments was $7.7 million in Q2 2023, with the low at $583000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 17.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Trevi Therapeutics | 2.63 Bn | 2.63 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 7.66 Mn |
| Jun 30, 2023 | 7.66 Mn |
| Mar 31, 2023 | 1.75 Mn |
| Mar 31, 2023 | 1.75 Mn |
| Dec 31, 2022 | 1.75 Mn |
| Dec 31, 2022 | 1.75 Mn |
| Sep 30, 2022 | 1.75 Mn |
| Sep 30, 2022 | 1.75 Mn |
| Jun 30, 2022 | 1.75 Mn |
| Jun 30, 2022 | 1.75 Mn |
| Mar 31, 2022 | 583,000.00 |
| Mar 31, 2022 | 583,000.00 |
| Sep 30, 2018 | 1,000.00 |
| Sep 30, 2018 | 1,000.00 |
| Jun 30, 2018 | 2.75 Mn |
| Jun 30, 2018 | 2.75 Mn |
| Mar 31, 2018 | 2.06 Mn |
| Mar 31, 2018 | 2.06 Mn |